Hong Kong Exchange
Caproasia.com | The leading source of data, research, information & resource for investment managers, professional investors, UHNW & HNW investors, and advisors to institutions, billionaires, UHNWs & HNWs. Covering capital markets, investments and private wealth in Asia. How do you invest $3 million to $300 million? How do you manage $20 million to $3 billion of assets? Caproasia - Learn more

This site is for accredited investors, professional investors, investment managers and financial professionals only. You should have assets around $3 million to $300 million or managing $20 million to $3 billion.







Hong Kong Launches New Hang Seng China Metaverse Index and Hang Seng Shanghai-Shenzhen-Hong Kong Genomics & Oncology Index 

26th May 2022 | Hong Kong

Hong Kong Indexes Company, as part of the Megatrend Index Series based on innovative & transformative themes in Mainland China, has launched 2 new indexes: Hang Seng China Metaverse Index and Hang Seng Shanghai-Shenzhen-Hong Kong Genomics & Oncology Index.  Daniel Wong Director & Chief Index Officer at Hang Seng Indexes Company: “New megatrends are having an increasingly significant impact on our daily lives. Our two new megatrend indexes are designed to help investors capture potential opportunities arising from these innovative and transformative trends in the mainland China and Hong Kong stock markets.” 

“ New Hang Seng China Metaverse Index and Hang Seng Shanghai-Shenzhen-Hong Kong Genomics & Oncology Index “

 


Ads & Announcements



Hang Seng Indexes Co

Hong Kong Exchange

Hang Seng Indexes Co: Developments as part of the metaverse concept, which includes virtual reality (VR), gaming and other digital experiences that use advanced technology in virtual spaces, have captured the attention of people around the world and are rapidly growing in popularity as investment themes among investors. Riding on this trend, the Hang Seng China Metaverse Index aims to reflect the performance of mainland China companies that are involved in metaverse-related business, value chains and development. As genomic medicine and innovative drugs develop as mainstream treatments for cancer and other diseases, the Hang Seng Shanghai-Shenzhen-Hong Kong Genomics and Oncology Index aims to track the performance of companies that are involved in the research and development of genomics or oncology-related products and services.

The index universe for each of the two indexes covers stocks listed in Shanghai, Shenzhen and Hong Kong. The two new indexes, which are calculated and disseminated in real-time at two second intervals, enriches the Hang Seng Megatrend Index Series, which also includes the Hang Seng Shanghai-Shenzhen-Hong Kong E-Commerce Index, the Hang Seng Shanghai-Shenzhen-Hong Kong NextGen Communications Index, and the Hang Seng Shanghai-Shenzhen-Hong Kong Generation Z Index. 

About Hang Seng Indexes Company Limited 

Hang Seng Indexes Company Limited (‘Hang Seng Indexes Company’) manages and compiles the Hang Seng Family of Indexes, which cover stocks listed in Hong Kong and Mainland China. Our index series includes the Hang Seng Index, the Hang Seng China Enterprises Index and the Hang Seng TECH Index, as well as Stock Connect, Greater Bay Area and sector-related indexes. As at the end of 2021, assets under management in products passively tracking indexes in the Hang Seng Family of Indexes had reached a total of about USD44 billion. Hang Seng Indexes Company is a wholly owned subsidiary of Hang Seng Bank. For further information on the Hang Seng Family of Indexes, please visit www.hsi.com.hk 




2021 Data Release
2020 List of Private Banks in Hong Kong
2020 List of Private Banks in Singapore
2020 Top 10 Largest Family Office
2020 Top 10 Largest Multi-Family Offices
2020 Report: Hong Kong Private Banks & Asset Mgmt - $4.49 Trillion
2020 Report: Singapore Asset Mgmt - $3.48 Trillion AUM

Register Below
Latest 2022 data & reports, insights & news
Every Saturday & Sunday 2 pm
Direct to your inbox
Save 2 to 8 hours per week. Organised for success

For Investors | Professionals | Executives




New to Caproasia?
Join 10,000 +
Learn More | Sign Up Today







For CEOs, Heads, Senior Management, Market Heads, Desk Heads, Financial Professionals, Investment Managers, Asset Managers, Fund Managers, Hedge Funds, Boutique Funds, Analysts, Advisors, Wealth Managers, Private Bankers, Family Offices, Investment Bankers, Private Equity, Institutional Investors, Professional Investors

Get Ahead in 60 Seconds. Join 10,000 +
Save 2 to 8 hours weekly. Organised for Success.

Subscribe / Sign Up / Contact Us


    Mailing ListFree TrialPromo $20 MonthlyPromo $180 YearlyInvestor $680 YearlyProfessional $680 YearlyExecutive $2,000 Yearly


    Private WealthFamily OfficePrivate BankingWealth ManagementInvestmentsAlternativesPrivate MarketsCapital MarketsESG & SICEO & EntrepreneursTax, Legal & RisksHNW & UHNWs Insights











    Caproasia | Driving the future of Asia
    a financial information technology co.
    since 2014


    Web links may be disabled on mobile for security.
    Please click on desktop.









    Previous articleSingapore MAS Bans Individual for 8 Years & 8 Months Imprisonment,  Raised S$15.3 Million from 145 Individuals for SMEs without CMFAS License
    Next articleHSBC Grows Private Banking in China in 6 Cities & 100 New Hires in 2022, Launches HSBC Premier Elite for Affluent Clients
    Caproasia.com covering capital markets, investments and private wealth in Asia. Our users manage, advise & invest $25 trillion assets in Asia